IE 11 is a very old Browser and it`s not supported on this site

Consolidated statement of changes in equity

(in CHF 1 000)

 

 

Share capital

 

Treasury shares

 

Retained earnings

 

Total

Balances at January 1, 2020

 

11 080

 

 

3 381 893

 

3 392 973

Dividend

 

 

 

(188 360)

 

(188 360)

Total comprehensive income for the period

 

 

 

26 489

 

26 489

Balances at September 30, 2020

 

11 080

 

 

3 220 022

 

3 231 102

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances at January 1, 2021

 

11 080

 

(8 241)

 

3 884 708

 

3 887 547

Dividend

 

 

 

(199 440)

 

(199 440)

Trade with treasury shares (incl. change in balance)

 

 

2 873

 

1 158

 

4 031

Total comprehensive income for the period

 

 

 

141 097

 

141 097

Balances at September 30, 2021

 

11 080

 

(5 368)

 

3 827 523

 

3 833 235

The notes are an integral part of the condensed consolidated interim financial statements.

BB Biotech AG uses cookies to improve website usability and ensure the best possible user experience.Use of cookies & disclaimer